Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Faries

Showing results (101-110 of 145) with videos related to

Pageof 15
Sort By:
JAMA Network Open|February 6, 2024
Smoking Status and Survival in Patients With Early-Stage Primary Cutaneous MelanomaKatherine M Jackson, Peter C Jones, Laura M Fluke, et al.
Annals of Surgery|December 29, 2011
Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanomaSojun Hoshimoto, Mark B Faries, Donald L Morton, et al.
Frontiers in Oncology|June 7, 2014
Clinical Benefit from Ipilimumab Therapy in Melanoma Patients may be Associated with Serum CTLA4 LevelsAnna M Leung, Agnes Fermin Lee, Junko Ozao-Choy, et al.
Annals of Surgical Oncology|October 12, 2012
Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanomaVernon K Sondak, Dennis W King, Jonathan S Zager, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 5, 2022
Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)Alistair J Cochran, Duan-Ren Wen, Rong-Rong Huang, et al.
Annals of Surgical Oncology|April 24, 2019
Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on SurvivalDaniel C Thomas, Gang Han, Stanley P Leong, et al.
Annals of Surgical Oncology|July 9, 2010
The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I)Mark B Faries, John F Thompson, Alistair Cochran, et al.
Annals of Surgical Oncology|October 12, 2017
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma MetastasesMark B Faries, Nicola Mozzillo, Mohammed Kashani-Sabet, et al.
Surgical Endoscopy|December 9, 2016
Laparoscopic skill assessment of practicing surgeons prior to enrollment in a surgical trial of a new laparoscopic procedureBenjamin Zendejas, James W Jakub, Alicia M Terando, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2017
Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline UpdateSandra L Wong, Mark B Faries, Erin B Kennedy, et al.
Pageof 15

Showing results (101-110 of 145) with videos related to

Sort By:
Pageof 15
JAMA Network Open|February 6, 2024
Smoking Status and Survival in Patients With Early-Stage Primary Cutaneous MelanomaKatherine M Jackson, Peter C Jones, Laura M Fluke, et al.
Annals of Surgery|December 29, 2011
Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanomaSojun Hoshimoto, Mark B Faries, Donald L Morton, et al.
Frontiers in Oncology|June 7, 2014
Clinical Benefit from Ipilimumab Therapy in Melanoma Patients may be Associated with Serum CTLA4 LevelsAnna M Leung, Agnes Fermin Lee, Junko Ozao-Choy, et al.
Annals of Surgical Oncology|October 12, 2012
Combined analysis of phase III trials evaluating [⁹⁹mTc]tilmanocept and vital blue dye for identification of sentinel lymph nodes in clinically node-negative cutaneous melanomaVernon K Sondak, Dennis W King, Jonathan S Zager, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 5, 2022
Sentinel lymph node melanoma metastases: Assessment of tumor burden for clinical prediction of outcome in the first Multicenter Selective Lymphadenectomy Trial (MSLT-I)Alistair J Cochran, Duan-Ren Wen, Rong-Rong Huang, et al.
Annals of Surgical Oncology|April 24, 2019
Recurrence of Melanoma After a Negative Sentinel Node Biopsy: Predictors and Impact of Recurrence Site on SurvivalDaniel C Thomas, Gang Han, Stanley P Leong, et al.
Annals of Surgical Oncology|July 9, 2010
The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I)Mark B Faries, John F Thompson, Alistair Cochran, et al.
Annals of Surgical Oncology|October 12, 2017
Long-Term Survival after Complete Surgical Resection and Adjuvant Immunotherapy for Distant Melanoma MetastasesMark B Faries, Nicola Mozzillo, Mohammed Kashani-Sabet, et al.
Surgical Endoscopy|December 9, 2016
Laparoscopic skill assessment of practicing surgeons prior to enrollment in a surgical trial of a new laparoscopic procedureBenjamin Zendejas, James W Jakub, Alicia M Terando, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 13, 2017
Sentinel Lymph Node Biopsy and Management of Regional Lymph Nodes in Melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline UpdateSandra L Wong, Mark B Faries, Erin B Kennedy, et al.
Pageof 15